1.61

1.26% 0.02

After Hours: 1.60 -0.01 -0.62%

Filana Therapeutics Inc (FLNA)

Overview News Price History Discussions Forecast

Filana Therapeutics Inc stock is traded at $1.61, with a volume of 380.60K. It is up +1.26% in the last 24 hours and down -19.10% over the past month. Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Previous Close:

$1.59

Open:

$1.6

24h Volume:

380.60K

Relative Volume:

2.71

Market Cap:

$77.78M

Revenue:

Net Income/Loss:

$-90.97M

P/E Ratio:

-0.8547

EPS:

-1.8837

Net Cash Flow:

$-32.83M

1W Performance:

-5.29%

1M Performance:

-19.10%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$1.535

$1.62

1-Week Range:

$1.535

$1.74

52-Week Range:

$1.535

$2.0901

Filana Therapeutics Inc Stock (FLNA) Company Profile

Name

Filana Therapeutics Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

512-501-2444

Address

6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN

Employee

Twitter

Next Earnings Date

2026-03-16

Latest SEC Filings

FLNA's Discussions on Twitter

Compare FLNA vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLNA Filana Therapeutics Inc	1.61	76.81M	0	-90.97M	-32.83M	-1.8837
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Filana Therapeutics Inc Stock (FLNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-26-24	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-08-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jul-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-16-22	Downgrade	B. Riley Securities	Buy → Neutral
Jul-15-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-07-21	Reiterated	Maxim Group	Buy
Apr-27-21	Initiated	B. Riley Securities	Buy
Feb-16-21	Reiterated	H.C. Wainwright	Buy
Oct-23-20	Initiated	Cantor Fitzgerald	Overweight
Sep-23-20	Upgrade	H.C. Wainwright	Neutral → Buy
May-18-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-15-20	Downgrade	Maxim Group	Buy → Hold
Jan-10-20	Reiterated	Maxim Group	Buy

View All

Filana Therapeutics Inc Stock (FLNA) Latest News

01:39 AM

Filana Therapeutics publishes simufilam preclinical data - TipRanks

01:39 AM

08:23 AM

Filana Therapeutics Publishes Study Highlighting Simufilam's Potential to Attenuate Seizure Progression in Tuberous Sclerosis Complex Model - Quiver Quantitative

08:23 AM

08:00 AM

In severe epilepsy mouse model, Filana drug slowed seizure worsening - Stock Titan

08:00 AM

Apr 14, 2026

FLNA Options Chain — NASDAQ:FLNA - TradingView — Track All Markets

Apr 14, 2026

Apr 13, 2026

FLNA Options Volatility — NASDAQ:FLNA - TradingView — Track All Markets

Apr 13, 2026

Apr 10, 2026

Filana Therapeutics Inc Live Share Prices and Trades. FLNA.US Live Streaming Share Prices. - London South East

Apr 10, 2026

Apr 03, 2026

Issuance/retirement of stock (net) of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView

Apr 03, 2026

FLNA Should I Buy - Intellectia AI

Apr 03, 2026

Apr 02, 2026

FLNA Stock Price, News & Analysis - Stock Titan

Apr 02, 2026